Standard BioTools Sells SomaLogic to Illumina for Up to $425 Million in Strategic Move
Standard BioTools Inc. has announced the sale of its SomaLogic division to Illumina for up to $425 million, marking a significant transformation for the company and bolstering its capabilities in advancing health and disease research.
2 minutes to read